ADC Therapeutics
ADCT
#8173
Rank
โ‚ฌ0.18 B
Marketcap
1,89ย โ‚ฌ
Share price
-7.55%
Change (1 day)
62.60%
Change (1 year)

Revenue for ADC Therapeutics (ADCT)

Revenue in 2024 (TTM): โ‚ฌ64.67 Million

According to ADC Therapeutics's latest financial reports the company's current revenue (TTM ) is โ‚ฌ68.22 Million. In 2023 the company made a revenue of โ‚ฌ62.92 Million a decrease over the revenue in the year 2022 that were of โ‚ฌ0.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ADC Therapeutics from 2020 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ64.67 M2.79%
2023 โ‚ฌ62.92 M-67.85%
2022 โ‚ฌ0.19 B553.41%
2021 โ‚ฌ29.94 M
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA